一种新的HPTLC图像分析方法,用于评估上腺体药物的相互作用和抗氧化特征
Larisa Silveșan1, Claudia Cimpoiu1, Dorina Casoni1
1Babeş-Bolyai University, Faculty of Chemistry and Chemical Engineering, 11 Arany Janos, Cluj-Napoca, 400028, Romania; Research Center for Advanced Chemical Analysis, Instrumentation and Chemometrics-ANALYTICA, Babeş-Bolyai University, Cluj-Napoca, Romania.
Journal of chromatography. A
|February 12, 2026
概括
这项研究引入了一种新的高性能薄层染色法与图像分析 (HPTLC-IA) 方法,以评估上腺药物的抗氧化活性. 该方法揭示了静止相相互作用如何显著影响药物的抗氧化剂概况.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分析化学 分析化学
- 生物化学 生化学
背景情况:
- 上腺体药物与生理环境相互作用,可能影响它们的特性.
- 评估药物的抗氧化剂概况对于了解它们的治疗效果和潜在副作用至关重要.
- 评估药物抗氧化活性的现有方法可能无法完全捕捉与生理介质的相互作用.
研究的目的:
- 开发和验证一种新的体外法,用于评估上腺体药物的抗氧化特征.
- 研究静止相极性对上腺体药物的抗氧化活性的影响.
- 为了将药物的脂性和极性与它们的保留行为和抗氧化能力相关联.
主要方法:
- 使用高性能薄层染色学与图像分析 (HPTLC-IA) 相结合.
- 使用不同极性的静止相 (凝,RP-8,RP-18W,CN,DIOL) 来模拟生理环境.
- 使用DPPH•和ABTS+•激素清除试验量化抗氧化活性,通过图像处理和多变量分析进行分析.
主要成果:
- 药物静止相相互作用显著调节了抗氧化剂活性;极相增强,而非极相减少了活性.
- 高极性上腺激素药物与凝产生强烈的相互作用,而脂性药物则有利于非极性相,表明膜透的潜力.
- 该HPTLC-IA方法成功地根据它们与不同静止相的相互作用区分了各种腺激素药物的抗氧化特征.
结论:
- 开发的HPTLC-IA方法为选上腺激素药物抗氧化活性变异提供了一种具有成本效益和新的方法.
- 静止相选择对于准确评估模拟生理相互作用中的药物抗氧化潜力至关重要.
- 这种方法有助于理解药物与生理介质成分的相互作用如何影响它们的抗氧化能力.
相关概念视频
Drug toxicity: Drug–Drug Interaction
2
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
2
Pharmacokinetics: Drug–Drug Interactions
469
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
469
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.0K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.0K
Drug-Receptor Interactions
7.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K
Drug Dissolution: Requirements and Profile Comparison
289
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
289
Factors Affecting Protein-Drug Binding: Drug Interactions
617
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
617


